Top 50 Biotech VC (Venture Capital) Funds in Israel in October 2024
A list of 50 VC (Venture Capital) funds that invest in Biotech startups based in Israel. We rank investors based on the number of investments they made in Biotech companies from Israel. We update this investor list every month.Top 50 Biotech VC (Venture Capital) Funds in Israel in October 2024
Pontifax is a healthcare-dedicated venture capital firm.The fund focuses on innovative bio-pharma opportunities.
Show more
Investment focus
- Biotechnology, Health Care, Therapeutics
- Series A, Series B, Series C
- United States, Israel, France
Portfolio highlights
- Abcuro — Precision Targeting of Highly Cytotoxic T Cells in Autoimmune Disease.
- Adcytherix — Adcytherix is a biopharmaceutical company focused on the development of novel antibody drug conjugates (ADC) to treat high unmet need diseases such as cancer.
- AgomAb Therapeutics — AgomAb is developing molecular therapies for the regeneration of damaged tissues. Their unique agonistic monoclonal antibody molecules (“agomAbs”) stimulate molecular and cellular repair mechanisms that have the potential to restore organ function in patients with fibrotic, inflammatory, autoimmune and degenerative diseases.
Trendlines Group invents, discovers, invests in, and incubates innovation-based medical and agrifood technologies. Trendlines invests principally through medical and agrifood incubators in Israel and in Singapore, its in-house innovation center, Trendlines Labs, and its Funds - the Trendlines Agrifood Fund and the Bayer Trendlines Ag InnovationFund.The company was founded in 1993 and is headquartered in Misgav, Israel.
Show more
Investment focus
- Biotechnology, Health Care, Medical Device
- Seed, Funding Round, Series A
- Israel, Singapore, United Kingdom
Portfolio highlights
- AgriG8 — AgriG8 is an enterprise designed to align, collaborate, de-risk and grow value chains and ecosystems within the agricultural industry.
- Peptobiotics — We make agriculture more productive, humane and sustainable by promoting growth and protecting against pathogens using a new new type of antibiotic alternative that does not cause resistance. Our recombinant peptides are synthetic biology products manufactured in a patent pending precision fermentation process. We are launching a range of products across livestock and aquaculture in Asia.
- ViAqua Therapeutics — ViAqua is developing the first orally administered treatment in aquaculture to stop diseases from developing and to prevent viral epidemics.
The Israeli innovation agency, the Innovation Authority, was established in 1965 as the Office of the Chief Scientist of the Ministry of Industry and Trade and was designed as a body that supports R & D conducted in the framework of government research institutes. Industrial development in order to increase industrial exports of high-techproducts. The Chief Scientist focused on reducing the risk by participating in financing the project, which the private companies chose and led.
Show more
Investment focus
- Health Care, Biotechnology, Medical Device
- Grant, Seed, Pre-Seed
- Israel, United States, Mali
Portfolio highlights
- BloomX — Helping nature do its magic with the power of technology
- Pickommerce — Pickommerce specializes in robotic grasping and focused on logistic solutions, primarily with our autonomous Pick & Pack integrated system. We are on a mission to promote work productivity and facility efficiency in logistic warehouses while ensuring seamless operation.
- NurExone Biologic — NurExone Biologic is developing a biological exosome based technology drug platform to treat damage in the Central Nerve System.
Access exclusive venture capital angel investment deals in pre-vetted startup companies. Create your free OurCrowd investor account today!
Show more
Investment focus
- Software, Artificial Intelligence, Machine Learning
- Series B, Series A, Seed
- Israel, United States, Canada
Portfolio highlights
- Carrar — A complete thermal management solution for electric vehicles dissipating heat faster and more efficiently than ever before. Thermal management for ev batteries.
- Jooules — Jooules offers a sustainable food system to ensure a greener, healthier future by using fermentation technologies to create nutritious protein ingredients.
- Metrovate — Metrovate is a biotechnology company which enhance global health and sustainability via sophisticated research and development.
Leading Global Healthcare Platform with Deep Proprietary Resources and Global Industry Coverage.
Show more
Investment focus
- Biotechnology, Health Care, Medical
- Series B, Series A, Series C
- United States, China, Israel
Portfolio highlights
- Chemomab — Pioneering Innovative Treatments for Patients with Fibrosis-Related Diseases
- MBX Biosciences — Homepage - MBX Biosciences
- Brenig Therapeutics — Brenig Therapeutics develops therapies for neurodegenerative disorders.
Docor International B.V. is a fully-owned subsidiary of Crecor B.V. Both Docor and Crecor were formed as wholly-owned subsidiaries of the Van Leer Group Foundation to promote and participate in commercial activities in Israel.
Show more
Investment focus
- Health Care, Biotechnology, Pharmaceutical
- Funding Round, Series C, Series A
- Israel, United States
Portfolio highlights
- Check-Cap — The first and only patient-friendly preparation-free test to detect polyps before they may transform into cancer
- Ocon Healthcare — OCON Healthcare innovates, develops, manufactures, and commercializes cutting-edge women’s health products based on our patented IUB™ (Intra Uterine Ball) proprietary platform. The IUB™, made from a super-elastic alloy Nitinol, is an ideal carrier for multiple drugs to the uterus to treat a variety of conditions.In addition to our flagshipproduct, the IUB™ Ballerine®, OCON healthcare is developing an innovative pipeline of products utilizing the IUB™ frame for indications such as abnormal uterine bleeding (AUB), heavy menstrual bleeding (HMS), myomas/fibroids, and infertility.
- Raziel Health — Raziel Health’s mission is to bring world-class, disruptively less expensive healthcare to everyone, in the comfort of their home. Its unique, integrated system combines easy-to-use technologies that support positive patient experience, enable timely clinical intervention, and meet individual patient goals while using data analytics to supportwellness and disease management.
Hadasit Bio-Holdings Ltd. ("HBL") was founded and floated on the Tel Aviv Stock Exchange (TASE : HDST ) and recently on the OTC (OTCBB : HADSY ) in order to allow public participation in the highly promising field of biotechnology.It serves as a precedent in biotech financing - for the first time, public investment is allowed toparticipate in a holding entity including companies based on IP generated by Israel’s foremost medical research center – Hadassah University Hospital ("HU").In addition to the public holdings (54%) – including major Israeli institutional investors, HBL is held by Hadasit (www.hadasit.co.il) (36%) and Consensus Business Group (http://www.consensusbusiness.com) (10%). The traded stock, as a unique investment vehicle, provides investment exposure to a select cluster of 6 biotech companies - all based on inventions developed and owned by HU.HBL is a publicly traded subsidiary of Hadasit Ltd. – the technology transfer company of the Hadassah University Hospital in Jerusalem, Israel. Hadasit was established for the purpose of promoting and commercializing the intellectual property (IP) and R&D capabilities generated by Hadassah, aimed at finding solutions to problems faced by modern medicine.
Show more
Investment focus
- Biotechnology, Medical, Health Care
- Funding Round, Series A, Series B
- Israel
Portfolio highlights
- ProtAb — ProtAb develops therapeutic agents that modulate cytokine regulation, tipping the balance toward anti-inflammatory signaling pathways in the treatment of autoimmune and inflammatory diseases. Its first product, Prozumab, is a monoclonal antibody with a novel mechanism of action. It is currently in late-stage preclinical development for thetreatment of inflammatory bowel disease or IBD, ulcerative colitis or UC, and rheumatoid arthritis or RA. It operates as a subsidiary of Hadasit Bio-Holdings. HBL is a publicly traded subsidiary of Hadasit, the technology transfer company of the Hadassah University Hospital in Jerusalem in Israel.
- KAHR medical — KAHR Medical ("KAHR") is pioneering the development of "third generation biological drugs," a unique class of proprietary fusion-protein molecules with clear and far-reaching advantages. KAHR's technology represents a paradigm shift in protein-based pharmaceuticals that will significantly expand available treatment optionsfor cancer and autoimmune disorders.
- Enlivex Therapeutics — Enlivex is a clinical-stage macrophage reprogramming immunotherapy company that targets diseased macrophages in patients with sepsis. The company develops an autologous and allogeneic drug pipeline for the treatment of autoimmune and inflammatory conditions such as Graft versus Host Disease (GvHD), solid organ transplant rejection, Crohn'sDisease, and other autoimmune and inflammatory disorders.The company's revolutionary approach is to induce immune tolerance by injecting apoptotic cells and facilitating their interaction with dendritic cells activates the body's innate, physiologic mechanism for down-regulating inflammation and autoimmunity.Enlivex is an Israeli-based cell immunotherapy company established in October 2005 by Professor Dror Mevorach, a world-renowned expert on clearance of dying (apoptotic) cells.
Arkin Holdings is dedicated to empowering companies that create breakthrough pharma, biotech, medical device, and digital health technologies. Our synergistic healthcare investments are focused on creating innovations that benefit humanity and enhance medical care. We offer extensive experience, with a track record of successful healthcareinvestments. Experts in the dynamic world of healthcare development, we provide the know-how and close accompaniment that helps our portfolio investments achieve substantial value and growth. Arkin Holdings currently has a healthcare portfolio of $1.5 billion through its 5 investment arms. Its investors include a substantial amount of Israel’s top-tier institutional investors.
Show more
Investment focus
- Biotechnology, Health Care, Medical
- Series A, Seed, Funding Round
- Israel, United States, Switzerland
Portfolio highlights
- MadeRight — We usher in a new era of sustainable fungi-based materials that deliver excellent performance. The future, as we see it, is a novel industrial chain based on biomaterials.
- Honeycomb — Honeycomb (fka Agilius) is the only place where you can buy a condo/apartment building master policy online in less than 3 minutes at a fraction of the cost! Instant, free, no hassle quotes, online everything and up to 40% savings. With all that we're bringing simplicity and transparency to the real estate insurance space for condoassociations (HOAs), building owners, property managers, and developers everywhere. This is what we do. This is all we do.
- Nocion Therapeutics — Nocion Therapeutics is a developer of novel pharmaceuticals intended to treat the conditions arising from neurogenic inflammation. The company is developing "nocions" which are a new kind of therapy that selectively affects actively firing nociceptors, enabling patients to provide targeted, robust and sustained relief for the treatment ofserious conditions including cough, itch, pain and inflammation.
aMoon is a leading healthtech & life sciences venture capital firm.
Show more
Investment focus
- Biotechnology, Health Care, Medical
- Series B, Series A, Funding Round
- United States, Israel, Switzerland
Portfolio highlights
- AltruBio — AltruBio is focused on developing targeted antibody therapeutics for the treatment of cancer and immune-related inflammatory diseases.AltruBio International in Delaware with principal office in SFO Bay Area California is a biopharmaceutical company integrated globally and virtually to develop targeted antibody therapeutics for the treatment ofcancer and immune-related inflammatory diseases.With its R&D foundation in Taipei Taiwan since June 2000, AbGenomics has been focusing on the discovery and development of novel therapeutics for unmet medical needs.Their R&D scientists built an efficient discovery platform to identify and validate novel antibody therapeutics.Currently, AbGenomics has several potential therapeutic antibodies targeting autoimmune diseases, pancreatic cancer, stomach cancer, colorectal cancer, ovarian cancer, lung cancer, and other solid tumors in various development stages.
- Eleos Health — Automate documentation, alleviate provider burnout, and elevate care quality with the CareOps Automation platform from Eleos Health.
- Ibex Medical Analytics — Ibex Medical Analytics develops AI-driven clinical decision support tools that help pathologists deliver more efficient, metric-driven, objective and accurate diagnosis. It combines AI, data science, image analysis and machine learning technologies and applies them to cancer diagnostics in digital pathology.
Impact investing in Israeli technology. ZORA is an impact investing fund investing in early-stage Israeli companies solving global challenges in health, education, economic inclusion and the environment.
Show more
Investment focus
- Health Care, Biotechnology, Internet
- Seed, Series A, Convertible Note
- Israel, United States, United Kingdom
Portfolio highlights
- BiotaX — Microbiome Genomic Analysis Cloud Platform | Biotax.co
- Newmoo — Newmoo makes plant-based cheeses and dairy alternatives.
- Forsea Foods — Forsea Foods develops cell-cultured seafood through the use of patented organoid technology which allows them to bypass the scaffolding stage of cultivated meat production.
Millennium Food-Tech is an R&D partnership traded on the Tel Aviv Stock Exchange that specializes in investment in and betterment of companies in food-tech sectors,. Millennium seeks to invest in companies that specialize in identifying and developing innovative, and transformative ideas in the food, drinks, and nutrition industry. Millenniumhas experienced management, proven solutions, and a supportive network to develop ideas and start-ups from early-stage to maturity to exit.
Show more
Investment focus
- Food and Beverage, Manufacturing, Agriculture
- Seed, Series A, Convertible Note
- Israel
Portfolio highlights
- ansā — Objectively Awesome Coffee
- Phytolon — Phytolon revolutionizes the way food colors are produce, by Leveraging a novel and sustainable technology for production of healthy food colors in high quality at low costs. Phytolon's mission is to exploit scientific advancement promote human health and environmental sustainability
- Supersmart — Supersmart is the world's leading loss-prevention solution for self-scan transactions. Supersmart uses its proprietary machine-learning, AI algorithm to validate all self-scanning transactions in physical stores. Our solution enables retailers to confidently provide self-scanning options to their customers, enhancing customer experiencewithout sacrificing potential loss.The Israel-based company was founded in 2014 by Yair Cleper and Amir Ayalon.
Invest in groundbreaking startups with iAngels. Discovercutting-edge technology and join a community of forward-thinking investors shapingthe future of entrepreneurship.
Show more
Investment focus
- Artificial Intelligence, Software, Financial Services
- Seed, Series A, Funding Round
- United States, Israel, United Kingdom
Portfolio highlights
- Mawari — Our mission is to unlock new perspectives with real-time immersive technology powered by a decentralized network of global resources
- Shadow War — Shadow War is a 5v5 competitive PvP action game for PC and Console. Fight online in a futuristic cyberpunk world
- Payouts — Payouts.com provides payouts automation for affiliates, freelancers, vendors & more. Experience faster, seamless payouts. Enjoy fast, automated payouts.
Clal Biotechnology Industries is a leading Israeli life sciences investment company traded on the Tel Aviv Stock Exchange (TASE: CBI)
Show more
Investment focus
- Biotechnology, Health Care, Medical
- Series A, Funding Round, Series B
- Israel, United States
Portfolio highlights
- Sight Diagnostics — Combining AI and breakthrough hardware to bring lab-quality CBC results to the doctor's office.
- Cadent Therapeutics — Cadent Therapeutics is a precision neuroscience company developing novel medicines that tune and modulate brain rhythms to restore cognitive and motor function in patients with serious neurological disease. The company leverages its precision neuroscience approach combining target specificity, patient selection, drug design and optimization, andnovel quantitative endpoints to create first-in-class molecules to treat movement and cognitive disorders.It was founded in 2010 and headquartered in Cambridge, Massachusetts.
- Elicio Therapeutics — Elicio ground-breaking Amphiphile technology is engineering potent vaccines and immunotherapies to defeat an array of aggressive cancers.
Takeda Ventures, Inc. (TVI) is the corporate investment arm of Takeda Pharmaceutical Company Limited (TPC). TVI was founded in 2001 and invests in current and future areas of interest for TPC. They are based alongside Takeda’s R&D sites in Cambridge, MA, and San Diego, CA. As a strategic investor, TVI aims to provide support and guidance toentrepreneurs and early-stage companies driving concepts through clinical proof of concept. They also strive to forge active, collaborative interactions that result in synergies with Takeda's considerable R&D resources. Their goal is to build a portfolio of strategic investments, with an immediate emphasis on oncology, gastroenterology, neuroscience, and rare diseases.
Show more
Investment focus
- Biotechnology, Health Care, Therapeutics
- Series A, Series B, Funding Round
- United States, United Kingdom, Israel
Portfolio highlights
- OncoResponse — OncoResponse Inc., an immuno-oncology company located in Houston, Texas, has partnered with MD Anderson Cancer Center (MDACC) to deploy a unique and transformational approach to cancer therapeutic monoclonal antibody and target discovery. The company licensed the I-STAR™ platform, developed and validated by Theraclone Sciences of Seattle, tointerrogate the human memory B-cell repertoire of cancer patients who are considered “Elite Responders” to immunotherapy; as such, their own adaptive immune system responded to immunotherapy stimulation in a way that achieved curative or durable responses. From these Elite Responders, OncoResponse is leveraging the human immune system to identify fully human monoclonal antibodies and discover novel targets that will lead to the development of fully human antibody derived therapeutics for the treatment of cancer.
- Larkspur Biosciences — Larkspur's strategy focuses on the particular ways in which tumours hijack the immune system by developing precision immunotherapies for molecularly defined patient groups to overcome the bottlenecks that allow the tumour to subvert the immune system.
- EvolveImmune Therapeutics — EvolveImmune Therapeutics transforms the discovery and development of novel immunotherapies. By leveraging its proprietary in vivo target discovery platform, EvolveImmune is building a pipeline of novel therapeutic candidates against numerous targets that are expressed on multiple immune cell types. The company’s platform will generatefirst-in-class treatments for unmet needs in oncology and autoimmune diseases.
S2G Ventures is is a multi-stage venture fund investing in food and agriculture. We're harnessing the power of food innovation to create better outcomes for people and the planet.
Show more
Investment focus
- Food and Beverage, Agriculture, Biotechnology
- Series A, Series B, Funding Round
- United States, Canada, Israel
Portfolio highlights
- Catalera — Catalera BioSolutions offers proprietary bio-based pest control products to enhance the well-being of people, plants, and planet.
- Exacto — Exacto is an innovative turnkey adjuvant manufacturer for agricultural, T&O and industrial vegetation management markets.
- Amperage — Amperage provides a full-service platform that focuses on directly investing and growing broadband infrastructure.
Healthcare innovation wherever it originates.
Show more
Investment focus
- Biotechnology, Health Care, Medical
- Series A, Series B, Series C
- United States, Israel, United Kingdom
Portfolio highlights
- Moon Surgical — MastOR is a medical device company developing a surgical robot for laparoscopy assistance. MastOR is an early-stage surgical robotics company whose laparoscopy assistance platform broadens access to minimally-invasive techniques for surgeons and optimizes resource utilization in the operating room.
- Artera — Discover the power of Personalized Precision Medicine & AI Cancer Therapy with Artera. Transforming cancer therapy through innovation.
- ONL Therapeutics — ONL Therapeutics develops innovative therapeutics to protect and improve the vision of patients with a range of retinal diseases and conditions.
Our expert team is the first to examine and evaluate the Hebrew University's biomedical breakthroughs. We then capitalize decades of experience - transforming the inventions into pioneering companies.
Our golden eggs
Ayana Pharma
A late stage company with
Show more
Investment focus
- Biotechnology, Pharmaceutical, Life Science
- Seed, Series B, Series F
- Israel
Portfolio highlights
- BacoCure — BacoCure is developing a novel bacterial product for local therapy of non-muscle invasive bladder cancer (NMIBC) patients.
- Splisense — Splisense is develops antisense oligonucleotide based therapies to target genetic diseases caused by splicing mutations. The company has developed a compound to cure the lung disease in cystic fibrosis patients carrying a specific splicing mutation. It is also developing a targeted modulation approach to correct the splicing pattern of CFTRtranscripts according to the specific mutation carried.
- Rebiotic Rx — Develops nanotechnology-based antibiotics with the focus on resistant bacteria
Accelmed is a venture capital firm that funds private and public medical device companies with significant market potential and proven clinical data.Concentrating on medical device companies that have already reached the revenue stage enables the firm to assist companies in benefiting from its managerial capabilities and financial resources.Together with the management teams of their portfolio companies, the Accelmed can steer the way from the clinical-stage to a profitable business with a clear commercial plan, thereby accelerating the path to a successful exit.In 2009, Mori Arkin and Uri Geiger, the co-founders of Accelmed, established the firm in Herzliya, Tel Aviv.
Show more
Investment focus
- Health Care, Medical Device, Medical
- Funding Round, Series A, Series D
- Israel, United States
Portfolio highlights
- Revamp Medical — Revamp medical was founded in 2016 with the goal of resolving one of the most urgent unmet needs in Acute Heart Failure patients. Targeting a market of >1M annual admissions in the US with a direct cost of $65B, Revamp is set to deliver an easily adoptable solution using its patented temporary catheter, Doraya™.Revamp has a seasoned team ofprofessionals with a proven track record in leading multiple med-tech startups.
- Minerva Surgical — Minerva Surgical develops minimally invasive devices to treat the root causes of Abnormal Uterine Bleeding.
- Click Therapeutics — Click Therapeutics develops and commercializes software as medical treatments for people with unmet medical needs. Through cognitive and neurobehavioral mechanisms, Click’s Digital Therapeutics™ enable change within individuals, and are designed to be used independently or in conjunction with biomedical treatments. The Clickometrics® adaptive datascience platform continuously personalizes user experience to optimize engagement and outcomes. Following a groundbreaking clinical trial, Click’s industry-leading smoking cessation program is available nationwide through a wide variety of payers, providers, and employers. Click’s lead prescription program is entering into a multi-center, randomized, controlled, parallel-group, phase III FDA registration trial for the treatment of Major Depressive Disorder in adults.
Neo Ventures is the first open-ended early stage investor, based in Eastern Europe. The founders have backed more than 30 startups and exited 10 successfully. We invest in game-changing businesses, without geographic limitations. We partner with exceptional founder teams to challenge incumbents in markets ripe for change or to create entirely newmarkets. Neo Ventures funds and then supports the founders in business planning, scaling operations, follow-on investments, making the best of each opportunity and dealing with hard situations. Our investment focus is on data analytics, computer vision and remote sensing addressing disruptive opportunities across the high-growth SpaceTech, BioTech and Security verticals.
Show more
Investment focus
- Software, Artificial Intelligence, Aerospace
- Seed, Funding Round, Series A
- Israel, United Kingdom, Estonia
Portfolio highlights
- EnduroSat — At EnduroSat, we engineer, build and operate exceptional satellites. Our Mission is to make space universally accessible
- Cyberwrite — TRUSTED BY INDUSTRY LEADERS One platform to accelerate value across the cyber insurance lifecycle THE LATEST FROM CYBERWRITE
- GemmaCert — The easy-to-use GC-PRO by GemmaCert for quick and accurate potency analysis of cannabis and hemp, including for THC, CBD, and CBG.
Triventures is a global, early stage fund that invests in exceptional entrepreneurs. We partner with disruptive ventures with innovative breakthroughs in healthcare and beyond. Our vision is to create a better, healthier future through data driven solutions and cross industry convergence.
Show more
Investment focus
- Health Care, Medical Device, Medical
- Funding Round, Series B, Seed
- United States, Israel, Ireland
Portfolio highlights
- FEMSelect — More than half of women over 50 are living with Pelvic Organ Prolapse. Learn about EnPlace, the minimally invasive approach to Pelvic Organ Prolapse.
- Future Family — Our loans for IVF & egg freezing make it easy for you to get started quickly with fertility treatment. Learn more about our Fertility Financing & Loans today!
- Brightside Health — Get anxiety and depression treatment online from licensed psychiatric providers and therapists. No need to wait, start a free consultation online today.
SciSparc Ltd. is a specialty clinical-stage pharmaceutical company led by an experienced team of senior executives and scientists. Our focus is creating and enhancing a portfolio of technologies and assets based on cannabinoid pharmaceuticals. With this focus, the company is currently engaged in the following drug development programs based ontetrahydrocannabinol (THC) and/or non-psychoactive cannabidiol (CBD): THX-110 for the treatment of Tourette syndrome and for the treatment of obstructive sleep apnea; THX-160 for the treatment of pain; and THX-210 for the treatment of autism spectrum disorder and epilepsy.
Show more
Investment focus
- Pharmaceutical, Cannabis, Biopharma
- Funding Round, Corporate Round
- Israel
Portfolio highlights
- LaraPharm — LaraPharm Ltd. is a group of people joined together by the belief that active components found in the Cannabis plant can provide a real answer to hundreds of types of disease currently not addressed at all, or poorly addressed.
- MitoCareX Bio — MitoCareX Bio is a biotechnology company that focuses on the discovery and development of drugs for cancers & other life-threatening diseases.
Binder & Partners Ventures is the investments' capital arm of Binder & Partners multi-family office. The ambition of BPV is to connect our investors with the most promising startup companies.
Show more
Investment focus
- Software, Information Technology, Health Care
- Seed, Pre-Seed, Series A
- Israel, France, United States
Portfolio highlights
- Rookout — Speed up the debugging process and accelerate your team's velocity with Rookout's live, remote debugging platform. Debug anything, anywhere. Effortlessly.
- Lumen — Lumen is a device and app that measures your metabolism in a single breath and provides daily personalized nutrition based on your metabolic data. Through the device and app, you can achieve your fitness goals whether they be weight loss, performance optimization, or simply improving your metabolic health.As a company, we are a team ofscientists, researchers, engineers, and designers, aimed at improving the way people understand their metabolism. We believe that a healthy metabolism is a key to better health and that everyone can attain it with a little help from Lumen.At Lumen, we are all about teamwork, friendship, and family. Curious about joining? We are always looking for creative people who share our passion for health and fitness to join our team.
- Blink Technologies — Blink creates the ultimate interaction between your eyes & the world around you with our eye tracking software & eye tracking technology.
The Office of the Chief Scientist [OCS] in the Ministry of Economy is charged with execution of government policy for support of industrial R&D. The goal of the OCS is to assist in the development of technology in Israel as a means of fostering economic growth, encouraging technological innovation and entrepreneurship, leveraging Israel’sscientific potential, enhancing the knowledge base of industry in Israel, stimulating high value-added R&D and encouraging R&D collaboration both nationally and internationally. A variety of ongoing support programs developed and offered by the OCS play a major role in enabling Israel to be a key center for high tech entrepreneurship.
Show more
Investment focus
- Health Care, Biotechnology, Hardware
- Seed
- Israel
Portfolio highlights
- LapSpace — LapSpace Medical was founded in 2011. It operates within the framework of the Misgav Venture Accelerator, part of The Trendines Group. The LapSpace team combines strong business and medical experience and knowledge.
- Digma Medical — Digma Medical | DiaGone - safe, one-time, 30 minute, minimaly-invasive, GI procedure for Restoring Glycemic Control for T2DM & NASH patients | No Implant
- Immunovative Therapies — Immunovative Therapies is a biopharmaceutical company with financial support of the Israel Office of the Chief Scientist. ITL is a graduate of the Misgav Venture Accelerator, a member of the world renown Israel technological incubator program. The company was the Misgav Venture Accelerator's candidate for the prize for the outstandingincubator project of 2006, awarded by the Office of the Chief Scientist. They specialize in the development of novel immunotherapy drug products that incorporate living immune cells as the active ingredients for the treatment of cancer and infectious disease.
FutuRx is the Israeli biotechnology accelerator that was established in 2014 by OrbiMed Israel Partners, Johnson & Johnson Innovation and Johnson & Johnson Development Corporation (JJDC) and Takeda Ventures Inc. following winning the tender of the Office of the Chief Scientist (OCS), Ministry of Economy, in Israel.The incubator willadvance new biotechnology products by identifying and nurturing early-stage life science innovation.FutuRx is located in the Weizmann Science Park in Ness Ziona (near the Weizmann Institute), Israel.
Show more
Investment focus
- Biotechnology, Life Science, Biopharma
- Seed, Funding Round
- Israel
Portfolio highlights
- Ramino Bio — Ramino Bio is a private biotech company that develops an oral drug to treat metabolic diseases.Ramino has received funding totaling about $3.3 million since its beginning from the FutuRx biotech incubator, which is supported by the Israeli Innovation Authority, Takeda, J&J, OrbiMed, and RMPG. By speeding up their disintegration, our exclusivetechnology lowers the extra BCAA that is floating around.
- Protekt Therapeutics — ProteKt Therapeutics is a drug development company aiming to develop potent and selective oral inhibitors of the kinase PKR for the treatment of neurodegenerative and neuroinflammatory diseases. The company has raised a $4M pre-A round and graduated from the FutuRx accelerator in 2019.
- Bsense Bio Therapeutics — Bsense Bio Therapeutics is developing small molecules for the treatment of neuropathic pain. Bsense is pioneering a novel approach targeting multiple pain-related mechanisms using a single compound, to achieve greater efficacy and safety.
fresh.fund is an Israeli pre-seed venture capital fund investing in early-stage startups across segments and verticals.We're built to partner with early-stage founders from day one, often as the company's first institutional investors. Our model is refreshingly simple: up to $300,000 in pre-seed funding within <4 weeks and follow-oncapital as necessary.Check out our portfolio here >> https://www.fresh.fund/portfolio.
It's never too early to have a conversation about your startup.
Show more
Investment focus
- Health Care, FinTech, Education
- Seed, Pre-Seed, Series A
- Israel, United States, Norway
Portfolio highlights
- enso — enso offers AI-powered bot bundles to automate your marketing strategy. Perfect for small business owners, our bots handle social media, SEO, lead generation & much more. Start with a 7 days free trial or talk with one of our marketing experts today.
- Carbon Blue — Carbon Blue is developing an 'ocean-capture' scalable method for removing CO2 from the atmosphere. The company was founded by Iddo Tsur and Dan Deviri.
- Guardoc Health — Streamlining clinical compliance with AI-driven accuracy in charting to meet regulations, enhance patient care, and optimize revenue management.
Pitango VC is a venture capital firm focused on health-tech (Pitango Health-tech) and growth (Pitango Growth) investments in startups around the world in domains such as vertical SaaS, digital health, deep tech, fintech and insurance technology, devops, generative AI, Web3, and food tech.With two offices in Israel, Pitango currently managesseveral venture funds totaling over $2.8 billion in committed capital. It has invested in more than 250 companies.
Show more
Investment focus
- Software, Health Care, Information Technology
- Series A, Series B, Series C
- Israel, United States, China
Portfolio highlights
- Guardoc Health — Streamlining clinical compliance with AI-driven accuracy in charting to meet regulations, enhance patient care, and optimize revenue management.
- Quantum Source — Quantum Source is on a clear path to the most powerful, cost-effective, practical photonic quantum computer. Learn more.
- Magenta Medical — Founded in October, 2012, Magenta Medical Ltd. is a privately held company that is engaged in the development of novel device solutions for the treatment of acute and chronic heart failure.
Ziegler is a privately held investment bank, capital markets and proprietary investments firm.
Show more
Investment focus
- Health Care, Biotechnology, Mobile
- Series C, Series E, Series F
- United States, Israel
Portfolio highlights
- Aposense — Aposense (formerly NST) is a clinical-stage molecular imaging and drug development company, with a pipeline of products based on its patented platform technology for targeting apoptosis (programmed cell death) in vivo. The company translating the science of Apoptosis (programmed cell death) into personalized patient care in multiple diseasecategories, including oncology, cardiology, and neurology. Targeting of this important biological process in-vivo opens opportunities for real-time clinical imaging of disease activity and targeted therapy.Aposense specializing in the development of novel drugs and utilizing membrane electrical forces for trans-membrane of macromolecule drugs, mainly siRNA. It also developed rationally-designed molecular nano-motors (MNMs), being novel small-molecule chemical entities and its translation into kinetic energy for movement within the hydrophobic membrane core.Aposense was founded in 1996 and is headquartered in Petah Tiqva, HaMerkaz, Israel.
- MAKO Surgical — MAKO Surgical is a medical device company, markets its advanced robotic arm solution, joint specific applications for the knee and hip, and orthopedic implants for orthopedic procedures in the United States and internationally. The company offers MAKOplasty, a restorative surgical solution that enables orthopedic surgeons to treat patient specificosteoarthritic disease. It also provides robotic arm interactive orthopedic system (RIO) consisting of a tactile robotic arm utilizing an integrated bone cutting instrument; and a patient specific visualization component, which offers pre-operative and intra-operative guidance to the orthopedic surgeon, enabling tissue sparing bone removal, and accurate implant insertion and alignment.In 2011, The company was named the No.1 on the Technology Fast 500 as the fastest growing technology company by Deloitte and received the CSSEC Award for loyal, customer-focused staff members presented by the Technology Services Industry Association and ACE Award (Achievement in Customer Excellence) from MarketTools and Fast Tech Award as one of the 25 fastest growing technology companies in South Florida by South Florida Business Journal.MAKO Surgical was founded in 2004 and is headquartered in Florida, USA.
- MobileAccess Networks — Corning Everon Network Solutions offer in-building cellular solutions to meet a broad array of design scenarios and mitigate RF propagation challenges.
Early Stage VC
Show more
Investment focus
- Software, Biotechnology, Machine Learning
- Seed, Pre-Seed, Series A
- Israel, United States, United Kingdom
Portfolio highlights
- Enzymit — Enzymit's platform technology can build molecular machines that enable never before seen chemistry aiming to solve humanity's greatest challenges
- DeepCure — DeepCure is a Boston-based therapeutics company that harnesses advanced AI, physics-based tools and automation to discover novel small molecules for challenging targets. DeepCure currently has a lead asset in IND-enabling studies and other programs focused on drugging intractable targets that have t
- Genetika+ — Genetika+ is revolutionzing depression treatment. Using biological, medical and genetic data, GenetikaPlus develops personalized solution for every patient to help them recover better, faster.
Welltech Ventures is Israel’s leading fund focused exclusively on investing in the health and wellness space. We seek to partner with entrepreneurs who epitomize the Startup Nation’s ethos and are building paradigm-shattering companies that are making an impact in the wellness space. As thought leaders we work with global investors focused onaccessing and investing in the Israeli tech ecosystem’s most promising entrepreneurs.
Show more
Investment focus
- mHealth, Health Care, Biotechnology
- Seed, Funding Round, Pre-Seed
- Israel, United States
Portfolio highlights
- Antidote Health — AntidoteHealth.ai offers primary care on its telehealth app on a 24/7 basis, including prescriptions & more. Book your appointment today!
- Behavidence — Behavidence is a mental health application that generates a daily mental health score. It compares your digital behavior to other people with anxiety, depression and ADHD.
- Quris — Quris Technologies is an artificial intelligence (AI) innovator disrupting the pharmaceutical arena.
Acting as advisor to companies within the Tchenguiz Family Trust, Consensus Business Group has amassed a portfolio of over 300,000 residential freeholds worth over £4 billion and a commercial portfolio worth over £2 billion.Consensus Business Group has vast experience and a proven track record of acquiring stock directly from nationalhousebuilders and developers over 20 years.As a result of their strategic investment, Consensus Business Group is believed to be the largest owner and asset manager of residential freehold interests in the UK, representing in excess of 1% of the housing stock in England and 1.2% in Greater London.Their decisions are not subject to procrastinated board approval or credit committees and as a result they are able to perform quickly and consistently. They are not dependent on debt finance and they have immediate cash availability.Consensus Business Group prides itself on having the market knowledge and expertise to stand out from its competitors, and it is their diligent and efficient acquisition practices that ensure swift transactions.
Show more
Investment focus
- Health Care, Medical Device, Biotechnology
- Funding Round, Seed, Series B
- Israel, United States, United Kingdom
Portfolio highlights
- BioProtect — Visualize the Space Optimize prostate radiation treatment with confidence CT MRI CBCT A Visibly Different Solution Reproducible & Adjustable Create a un ...
- Exero Medical — Exero Medical is a medical device manufacturing company. It develops a biodegradable wireless sensor for early detection of anastomotic leaks following GI Surgery. Its system is designed to prevent complications by warning physicians of a potential leak, enabling early intervention.The company was founded in 2018 and is headquartered in OrYehuda, Israel.
- RepAir — RepAir develops a Direct Air Capture system based on a proprietary electrochemical cell technology that can capture CO2 from the air in gigaton scale. Powered solely by renewable energy, our system can be deployed at the site of carbon storage or utilizations, saving arable land and avoiding CO2 transport.
Yozma earned worldwide recognition as the founder of Israel's VC industry.
Show more
Investment focus
- Health Care, Medical, Software
- Funding Round, Series B, Seed
- Israel, United States, Australia
Portfolio highlights
- Illumigyn — Technology that we developed, creating high-resolution digital images with superior magnification that can substantially improve diagnostic accuracy.
- Meat.The End — MTE revolutionizes food production to create desired textures and provides a solution for food companies, by developing novel ingredients and technological solutions that enhance the texture properties of alternative protein products.
- UltraSight — UltraSight aims to revolutionize ultrasound through the power of machine learning to enable more accurate and timely clinical decisions. The UltraSight automated guidance system helps bring the benefits of cardiac imaging to healthcare professionals in new care settings, allowing patients access to ultrasound anywhere.
Merck Ventures is the strategic, corporate venture capital arm of Merck. Its mandate is to invest in innovative technologies and products with the potential to significantly impact Merck‘s core business areas. From its headquarters in Amsterdam and offices in the US and Israel we invest globally in transformational ideas driven by greatentrepreneurs. Merck Ventures takes an active role in its portfolio companies and teams up with entrepreneurs and co-investors to translate innovation towards commercial success. Merck Ventures has a significant focus on early-stage investing and company creation including the creation of spin-offs to leverage Merck‘s science and technology base.
Show more
Investment focus
- Biotechnology, Health Care, Therapeutics
- Series A, Series B, Seed
- United States, Switzerland, United Kingdom
Portfolio highlights
- Astraveus — Designing and building closed, automated, bioprocessing systems for the production of cell and gene therapies.
- Anavo Therapeutics — UNLOCKING THE PHOSPHATASE TARGET CLASS: Anavo Therapeutics is the first company to systematically drug phosphatases, a rich target space previously considered undruggable for decades.
- Celestial AI — We develop audacious AI computing platforms that elevate performance, energy and economic efficiencies, enabling our customers to rapidly deploy innovations in their AI applications.
Cancer Focus Fund is an investment firm that is dedicated to providing financial services to its clients.
The company was founded by Ross Barrett.
Show more
Investment focus
- Biotechnology, Medical, Health Care
- Funding Round, Seed, Series A
- Israel, United States, Germany
Portfolio highlights
- Eisbach Bio — Eisbach Bio is a biotechnology company that creates new drugs that target molecular vulnerabilities in cancer genomes. Screening and cellular platforms are yielding first-in-class inhibitors to directly target the key vulnerability found in genetically defined tumors. It is founded in 2019 and is based in Martinsried, Bavaria.
- ImmunoGenesis — We are rapidly translating the most cutting-edge discoveries from academic tumor immunology into drugs optimized for treating the majority of patients who have "cold" cancers refractory to currently available immunotherapy.
- March Biosciences — Transforming Patient Care by Unlocking New Target Spaces March Biosciences is a clinical-stage company in the cell therapy field focused on developing CAR-T cell strategies to address the most challenging hematological cancers Pipeline MB-105 https://march.bio/wp-content/uploads/2023/05/shutterstock_1008023995-HD-30.mp4 Focused on Excellence Target Space Our approach combines biological and engineering insights to enable target-unlock without the risk and complexity
Since the firm was founded in 1994, Jerusalem Global's goal has been to support private Israeli technology initiatives and to generate superior returns to investors. Over the last two decades, the partners of Jerusalem Global Ventures have developed strong ties with the top Israeli entrepreneurs and visionaries enabling JGV to invest in thebest of Israel's entrepreneurs and help their portfolio companies build winning management teams.
Show more
Investment focus
- Software, Information Technology, Biotechnology
- Series A, Series B, Series C
- United States, Israel, Canada
Portfolio highlights
- Moovit — Utilizing the power of MaaS, we're helping cities, transit agencies and corporations simplify urban mobility, making it more efficient, accessible and sustainable.
- Quiet Therapeutics — Quiet Therapeutics is an emerging biotech company founded in 2010 developing a proprietary nanoparticle-based delivery system (gagomers) focused on oncology and inflammation.Based on the targeting capability of our innovative technology, the company is well positioned to expand the drug target repertoire in cancer and inflammation. The Gagomerdelivery approach enables us to target cell components that are not manageable by other therapeutic agents like small molecules or antibodies.
- SolarEdge Technologies — Turn your businesses and homes into a sustainable energy hub with a SolarEdge inverter solution and the SolarEdge energy manager platform.
EIT Food is a European Knowledge and Innovation Community (KIC), which was set up to transform our food ecosystem. By connecting consumers with businesses, start-ups, researchers and students from around Europe, EIT Food supports innovative and economically sustainable initiatives which improve our health, our access to quality food, and our environment
Show more
Investment focus
- Biotechnology, Food and Beverage, AgTech
- Grant, Seed, Funding Round
- The Netherlands, United Kingdom, Israel
Portfolio highlights
- LenioBio — LenioBio develops rapid plant-based, cell-free protein expression that scales for research, development and production.
- 3D Bio-Tissues — 3D Bio-Tissues (3DBT) is a biotech startup spun-out from Newcastle University in 2019. Our ambition is to produce bio-equivalent tissues for clinical and cellular agriculture. We apply novel bio-inspired manufacturing processes to generate complex structures.
- BioBetter — BioBetter is a foodtech company that develops plant-based platforms for the production of complex growth factors used in cultivated meat. The company was founded in 2015 and is headquartered in Israel.
JJDC, Inc. is the strategic venture capital arm of Johnson & Johnson Innovation. Learn more about our equity investment strategy.
Show more
Investment focus
- Health Care, Biotechnology, Medical
- Series A, Series B, Series C
- United States, Israel, France
Portfolio highlights
- Nanobiotix — Nanobiotix is a biotechnology company pioneering novel, physics-based nanomedicines
- Aro Biotherapeutics — Aro Biotherapeutics is a biotechnology company pioneering the development of tissue-targeted genetic medicines with a platform based on a proprietary protein technology called Centyrins.
- On Target Laboratories — ON TARGET LABORATORIES discovers and develops fluorescent markers to target and illuminate cancer during surgery so it can be removed more completely.
RMGP Biopharma Investment Fund is an investment Fund
Show more
Investment focus
- Biotechnology, Biopharma, Health Care
- Seed, Series B, Funding Round
- Israel
Portfolio highlights
- Ramino Bio — Ramino Bio is a private biotech company that develops an oral drug to treat metabolic diseases.Ramino has received funding totaling about $3.3 million since its beginning from the FutuRx biotech incubator, which is supported by the Israeli Innovation Authority, Takeda, J&J, OrbiMed, and RMPG. By speeding up their disintegration, our exclusivetechnology lowers the extra BCAA that is floating around.
- Pi Therapeutics — Pi Therapeutics is a discovery-stage biopharmaceutical company aiming to develop a novel cancer drug. The company is financed by a syndicate of Takeda Pharmaceutical Company through its venture group Takeda Ventures Inc., Johnson & Johnson Innovation – JJDC, OrbiMed Israel Partners, Pontifax, and the Israel Innovation Authority, and hasoperated since March 2015 in the FutuRx biotech accelerator in Ness Ziona, Israel. The company’s mission is to develop novel first-in-class drugs directed against the ubiquitin-proteasome system (UPS), mainly for treatment of cancer.
- Protekt Therapeutics — ProteKt Therapeutics is a drug development company aiming to develop potent and selective oral inhibitors of the kinase PKR for the treatment of neurodegenerative and neuroinflammatory diseases. The company has raised a $4M pre-A round and graduated from the FutuRx accelerator in 2019.
We are an early stage venture capital fund passionate about helping entrepreneurs bring innovative solutions to market.
Show more
Investment focus
- Software, Information Technology, Artificial Intelligence
- Seed, Series A, Funding Round
- United States, Israel, Australia
Portfolio highlights
- qbiq — qbiq develops cutting-edge Artificial Intelligence, Generative Design, and Optimization Technologies to real-estate planning.With a click of a button, hundreds of cloud processors, loaded with thousands of years of architectural experience, process your planning request, analyze different layout alternatives, and optimize the results. In justseconds, we provide you with the best construction alternatives considering utilization, costs, build time, efficiency, and more.
- Fortify — 3DFortify is an advanced manufacturing startup that aims to disrupt additive manufacturing, ushering in a new generation of custom, high performance products. We have developed a patented process that combines 3D printing and magnetics to create aligned reinforced carbon fiber composites.
- Intracare Health Services — Intracare is a tech-enabled provider of complex drug and biologic infusion therapy coordinated under the supervision of a provider.
Morris Kahn bussiness in Aurum Ventures MKI and The Kahn Foundation an independent private philanthropic foundation.
Show more
Investment focus
- Biotechnology, Medical Device, Information Technology
- Seed, Series A, Series C
- Israel
Portfolio highlights
- Nucleix — OUR TESTS AIM TO DETECT CANCER EARLIER - WHEN TREATMENT CAN BE MOST EFFECTIVE FOR PATIENTS OUR PRODUCTS
- Scopio Labs — Scopio Labs is a provider of Full Field Morphology dedicated to unlocking the potential of imaging and AI in hematology. Uncovering actionable insights from vast amounts of data readily available in the average blood sample and bone marrow aspirate, Scopio's solutions will aim to showcase thousands of cells at scale in high resolution, toenable new hematology diagnostic methods.
- KidneyCure — KidneyCure offers a novel dimension to treating advanced Chronic Kidney Disease.
Tyson Ventures is the investment arm of Tyson Foods. We aim to be the strategic partner of choice for disruptive innovators transforming the food industry, and provide sustainable nutrition to a growing global population. Our current areas of interest focus on emerging proteins, technology enablers and sustainability. Let’s build the future offood... together.
Show more
Investment focus
- Food and Beverage, Biotechnology, Software
- Funding Round, Series B, Seed
- United States, Israel
Portfolio highlights
- Omeat — Omeat is real, lip-smacking meat, grown from cells, outside the animal. No sacrifice required.
- Athian — Funding livestock sustainability via a connected carbon marketplace.
- Soft Robotics — Soft Robotics is an industry-leading technology company that designs and builds AI-enabled visual inspection and bulk-picking solutions.
Join FoodTech focused investors looking to back impact-driven founders shaping our food system
Show more
Investment focus
- Biotechnology, Food and Beverage, Food Processing
- Seed, Pre-Seed, Series A
- United States, Israel, United Kingdom
Portfolio highlights
- twig bio — twig bio operates as a bioengineering startup. twig bio using AI and robotics to find sustainable replacements for harmful ingredients.
- RAAAM Memory Technologies Ltd. — RAAAM provides a unique on-chip memory technology that offers the highest-density embedded memory solution in any standard CMOS process.RAAAM develops a high-density memory technology that allows for up to 50% higher on-chip memory density with no cost, complexity, or performance-penalty.
- Cultivated Biosciences — Cultivated - Creamy, dairy-free indulgence
Israeli Early Stage Deep Tech Fund
Show more
Investment focus
- Information Technology, Software, Cyber Security
- Seed, Pre-Seed, Series A
- Israel
Portfolio highlights
- Wib Security — Wib is the only way to secure your APIs from development to production, with the most comprehensive full-lifecycle API Security Platform.
- Cydome — Cydome offers comprehensive maritime cybersecurity solutions for protecting IT and operational assets at sea, ensuring readiness for regulatory inspections.
- Cyngular Security — Cyngular Security - Cloud Autonomous Hunting, Investigation and Response Platform Helps organizations proactively prepare for and respond to cyber security incidents, ensuring maximum protection and minimum downtime.
PeakBridge is an Alternative Investment Fund Manager and Investment Services Firm specialized in FoodTech.
Show more
Investment focus
- Food and Beverage, Food Processing, Health Care
- Seed, Series A, Funding Round
- Israel, United States, United Kingdom
Portfolio highlights
- Mondra — AI-driven environmental insights platform that supports food system players to accelerate Scope 3 progress, reduce the cost of Net Zero, and drive competitive advantage.
- WNWN Food Labs — We're WNWN Food Labs and we love food. We're creating delicious, sustainable and ethical alternatives to unsustainable and ethically dubious foods. We're starting with cacao-free chocolate. Changing chocolate? It's Win-Win #alt-chocolate #altchocolate #alt-universe #altuniverse #alt-protein
- The Mediterranean Food Lab — The Mediterranean Food Lab merge traditional fermentation and cutting-edge science, to produce natural plant-based flavor-bases for a wide range of meat replacement needs.
SCP Vitalife is a Life Sciences Fundformed by SCP Partners , a U.S.-based investment organization with over $900 million in venture funds under management, and Vitalife , an experienced venture firm investing primarily in Israeli medical technology companies. The SCP Vitalife team includes investment professionals with prior experiences as seniorexecutives, clinical practitioners and venture capitalists.Their focus is on early to mid-stage life science technologies and services, with a concentration on therapeutic medical devices.They will continue to follow the successful formula of their predecessor fund, Vitalife Life Sciences Fund, offering their portfolio companies hands-on strategic assistance in planning, operations and finance. From their investment experience they have developed extensive networks to access capital, recruit management and facilitate favorable strategic alliances.
Show more
Investment focus
- Health Care, Medical, Medical Device
- Series C, Series D, Funding Round
- Israel, United States
Portfolio highlights
- MST Medical Surgery Technologies — Medical Surgery Technologies (MST) was founded in 2005 by Ziv Tamir and Moti Sholev, entrepreneurs with extensive experience in medical devices. MST leads the field of surgical analytics with its core image analytics technology designed to empower and automate the surgical environment, with a focus on medical robotics and computer-assisted surgery(MRCAS). The company's core technology is a software-based image analytics information platform powered by advanced visualization, scene recognition, artificial intelligence, machine learning and data analytics. The platform is positioned to enable the operating room of the future through real-time image analytics, connectivity and automation, providing value-added functionality for surgeon, provider and patient. MST’s initial offering is AutoLap™, the only robotic image-guided laparoscope positioning system. Powered by MST’s image-analysis software, AutoLap™ interacts with the surgeon’s movements in the surgical cavity, guiding the robotic laparoscope positioner in real time, offering the surgeon full and natural control of the surgical procedure and an optimal field of view.
- Ivenix — Bring the power of guided workflows, adaptive fluid delivery, and complete secondary delivery with an Ivenix IV Infusion System. Explore now.
- Rewalk Robotics — ReWalk Robotics is a medical device company that designs and develops powered solutions that provide gait training and mobility for lower limb disabilities.
OTV focuses on round A+ startups that aim to make a significant impact on people's lives. Our focus is on entrepreneurs with innovative ideas who are advancing the global state of well-being. Come join the digital health revolution, and be a part of transforming the healthcare industry.
Show more
Investment focus
- Health Care, Medical, Artificial Intelligence
- Series A, Series B, Seed
- United States, Israel, Ghana
Portfolio highlights
- Scopio — Buy & sell images on the largest Solana Photography NFT Marketplace. Find high-quality stock images & hire artists from around the world.
- Scopio Labs — Scopio Labs is a provider of Full Field Morphology dedicated to unlocking the potential of imaging and AI in hematology. Uncovering actionable insights from vast amounts of data readily available in the average blood sample and bone marrow aspirate, Scopio's solutions will aim to showcase thousands of cells at scale in high resolution, toenable new hematology diagnostic methods.
- Stake — Renters earn Cash back for rent. Building operators outperform the market. That's the Stake win-win. Find out how we're building the financial tools for the next generation of rentals.
Elron Ventures is an early-stage investor committed to turning promising ideas into global industry leaders, with a proven track record of investments and successful M&As worldwide. Elron invests in cyber security and B2B software. Since its establishment in 1962, Elron stands on the forefront of Israeli innovation both as a founder and earlyinvestor in companies across various industries such as Elbit, Medingo, Given Imaging, Cloudyn, Cyber Secdo, and Alcide.
Show more
Investment focus
- Information Technology, Health Care, Software
- Seed, Series A, Funding Round
- Israel, United States, China
Portfolio highlights
- Creednz — Creednz is a company that provides financial data management system that involves internal financial data sets.
- Entitle — Control access to your organizational cloud resources without creating bottlenecks or friction while creating a seamless experience for employees.
- Tamnoon — Tamnoon develops a state-of-the-art cloud security platform to empower security teams and manage cloud risks effectively. By harnessing the power of AI combined with human expertise, the company empowers security teams and equips organizations of all sizes with exceptional cloud protection capabilities.
Bits x Bites is a food tech VC that invests in early-stage startups tackling global food system challenges. It targets companies innovating across the food supply chain, from farming, production, distribution, and logistics, to consumer goods and food services.
Show more
Investment focus
- Biotechnology, Food and Beverage, Food Processing
- Series A, Seed, Series B
- China, Israel, Singapore
Portfolio highlights
- Ketai Bio — Ketai Bio is a synthetic biology company dedicated to the R&D, production and sales of high value-added bio-based products.
- Mojia Bioscience — Mojia Bioscience is a biotechnology company.
- Changjin Biotechnology — Changjin Biotechnology engages in the research, development, and industrialization of microbial synthetic proteins.
Arancia International Inc is a part of Arancia Group in Mexico. We are long term investors in food, nutrition and biotechnology companies.
Show more
Investment focus
- Health Care, Biotechnology, Life Science
- Series A, Series B, Funding Round
- Israel, United States, Malaysia
Portfolio highlights
- NextFerm — NextFerm is a science oriented industrial company, representing a new era in fermentation and fermentation-derived nutrients for supplements, food, infant nutrition and animal feed.The world is striving for better nutrition. Nutrition which is less artificial and more natural, sustainable and cost effective - with a much higher nutritional value.At Nextferm, they aim to use their capabilities to lead this new and exciting world of better nutrition.
- iwi Life — Algae is the ultimate source of Omega-3s. Research has proven that Omega-3s support cardiovascular health, a balanced mood, and healthy brain development.
- The Mediterranean Food Lab — The Mediterranean Food Lab merge traditional fermentation and cutting-edge science, to produce natural plant-based flavor-bases for a wide range of meat replacement needs.
ALIVE Israel HealthTech Fund is a pioneer mid-to-late stage HealthTech fund leveraging an exclusive ecosystem.
Show more
Investment focus
- Health Care, Medical, Biotechnology
- Series A, Funding Round, Series B
- Israel, United States
Portfolio highlights
- Append Medical — Append Medical develops a next-generation transcatheter Left Atrial Appendage (LAA) closure system.The Append Medical solution is in the pre-clinical in-vivo trial phase. It is intended to become a differentiated solution in the LAA closure market, which has been estimated to reach $25B within several years. This is the second-fastest growingsegment of the medical device market, with potential sales of $500M in 2019. Append Medical is a member of MEDX Xelerator, a medtech incubator backed by Boston Scientific, Intellectual Ventures, MEDX Ventures and Sheba Medical Center.
- Magenta Medical — Founded in October, 2012, Magenta Medical Ltd. is a privately held company that is engaged in the development of novel device solutions for the treatment of acute and chronic heart failure.
- Gina Life — At Nevia bio, we are focused on women's health. Our mission is to use innovative technologies to provide early detection of diseases through vaginal secretions analysis, enabled by Nevia's Machine Learning Platform.
BRM Capital is a dynamic venture capital fund investing in early stage, Israel-related software, internet infrastructure, and communication companies. Their investment focus is on the Internet, mobile and mobile applications, digital media, online services, enterprise software, and medical device sectors and they also offer flexible, streamlinedinvestment decision making.BRM headquartered in Tel Aviv, Israel enjoys a worldwide network of industry, strategic and financial experts.
Show more
Investment focus
- Software, Information Technology, Internet
- Series B, Series A, Funding Round
- United States, Israel
Portfolio highlights
- V-Wave — V-Wave Ltd. is a privately held company with offices in Israel and the US. The company is focused on developing percutaneous implantable devices for treating patients with Chronic Heart Failure (HF). V-Wave’s vision is to help patients who remain with disabling symptoms or need hospitalization despite optimized medical treatment. V-Wave hasdeveloped a proprietary interatrial shunt intended to relieve symptoms, reduce hospitalization, increase exercise capacity and improve the overall quality of life.The original concept and development started in Israel with a talented team of engineers and medical scientists. The company’s senior management has decades of experience successfully developing, clinically testing and bringing to market multiple implantable cardiovascular devices.
- ShopperAI — ShopperAI is a company that provides AI-powered shopper research and analytics tools to understand customer behavior and grow the business.
- Exceed Talent Capital — Exceed is an innovative platform to invest, earn, engage, influence, and celebrate Talent.
Investors by industry
Energy
Climate
Health Care
Gaming
Hardware
Artificial intelligence
Impact
Proptech
Marketplace
Community
FinTech
Google
Consumer
Biotech
EdTech
Sustainability
Venture Capital
Beauty
B2B
Photography
Finance
Real Estate
Big Data
Web3
Clean Energy
Oil and Gas
Video Games
Food and Beverage
Publishing
Education
Payments
Fashion
Organic Food
Social Media
Retail
Medical
Email
Art
Wellness
Music
Financial Services
Mobile
Franchise
Social Network
Local
Infrastructure
Internet
Digital Media
Construction
Platforms
Manufacturing
eSports
Mobile Advertising
Sports
Enterprise Software
Legal
Android
Biotechnology
Wine And Spirits
Hospitality
Medical Device
Fitness
Crowdfunding
Travel
Social
Automotive
CleanTech
Recruiting
Transportation
Mobile Apps
Cannabis
InsurTech
Enterprise
Non Profit
LGBT
Life Science
Theatre
Film
SaaS
Renewable Energy
Sporting Goods
Restaurants
Software
Celebrity
Social Impact
Agriculture (agtech)
Cryptocurrency
Media (entertainment)
Facebook
Blockchain
Investors by country
India
Germany
South Korea
United Kingdom
Australia
Ireland
New Zealand
Canada
United States
Spain
Indonesia
Singapore
South Africa
Africa
Qatar
Europe
LATAM
Middle East
Sri Lanka
Asia
Armenia
Vietnam
China
Japan
Saudi Arabia
Brazil
Czech Republic
Oceania
Ecuador
Barbados
Costa Rica
Finland
Belarus
Morocco
France
Estonia
Hong Kong
Denmark
Gibraltar
Malta
Chile
Bermuda
Belize
Georgia
Greece
Egypt
Hungary
Ethiopia
Faroe Islands
Algeria
Ghana
Belgium
Croatia
Bulgaria
Bahrain
Turkey
Serbia
Rwanda
El Salvador
Mali
Malaysia
Italy
Peru
Lithuania
Myanmar
Lebanon
Kuwait
Cayman Islands
Cambodia
Israel
Panama
Mexico
Kazakhstan
Liberia
Jersey
Philippines
Norway
Mauritius
Kenya
Liechtenstein
Nicaragua
Venezuela
Ukraine
Dominican Republic
Nigeria
Portugal
Sierra Leone
Zimbabwe
Sweden
Taiwan
Senegal
Azerbaijan
Namibia
Iceland
Uruguay
Uganda
Iraq
Bahamas
Tunisia
San Marino
Slovenia
United Arab Emirates
Zambia
Uzbekistan
Russian Federation
Honduras
Seychelles
Thailand
Bolivia
Puerto Rico
Tajikistan
Togo
Poland
Isle of Man
Tanzania
Albania
Luxembourg
Pakistan
Grenada
Jordan
Romania
Argentina
Bangladesh
Latvia
Cyprus
Oman
Guatemala
Austria
Cameroon
Switzerland
Colombia
Marshall Islands
VC (Venture Capital) Funds in Israel by industry
Restaurants
Venture Capital
Oil and Gas
Transportation
Education
Big Data
Finance
Cryptocurrency
Payments
Food and Beverage
Organic Food
Video Games
Medical
Medical Device
Wellness
Email
Internet
Social Media
Art
Digital Media
Social Network
Music
Manufacturing
Construction
Mobile
Sports
Legal
Enterprise Software
eSports
CleanTech
Automotive
Travel
Hospitality
Recruiting
InsurTech
Platforms
Mobile Advertising
Cannabis
FinTech
Biotechnology
Enterprise
Health Care
EdTech
Energy
Proptech
Sustainability
Impact
SaaS
Artificial intelligence
Marketplace
Community
Hardware
Gaming
Real Estate
Retail
Social
Infrastructure
Mobile Apps
Fashion
Web3
Beauty
Photography
Life Science
Clean Energy
Financial Services
B2B
Consumer
Social Impact
Publishing
Climate
Blockchain
Android
Agriculture (agtech)
Software
Renewable Energy
Fitness
Biotech
Media (entertainment)